Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Merck
Singulair
Pfizer
AstraZeneca
Sanofi
Forest Labs
Bristol-Myers Squibb
suvorexant
Eli Lilly
Bridon
V503
Endocyte
Tredaptive
Eli Lilly in Great Position with New Drug Amyvid
Motley Fool
Mon, 06/18/12 - 02:45 pm
Amyvid
Eli Lilly
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
ADA
diabetes
JNJ
Eli Lilly
Novo Nordisk
Sanofi
Bristol-Myers Squibb
8 Major Healthcare Stocks Yielding At Least 3.9% With P/E Ratios Under 18
Seeking Alpha
Tue, 06/12/12 - 11:03 am
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
Seeking Alpha
Sun, 06/10/12 - 11:17 am
Mindray
ShangPharma
Eli Lilly
WuXi PharmaTech
Hutchison MediPharma
Chi-Med
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company present new linagliptin data at American Diabetes Association's 72nd Scientific Sessions®
Yahoo/PR NewsWire
Sun, 06/10/12 - 11:10 am
linagliptin
type 2 diabetes
Boehringer Ingelheim
Eli Lilly
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor
PharmPro
Sat, 06/9/12 - 04:54 pm
Eli Lilly
Incyte
LY3009104
baricitinib
rheumatoid arthritis
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
Yahoo
Fri, 06/8/12 - 01:28 pm
Incyte
JAK inhibitors
baricitinib
Eli Lilly
rheumatoid arthritis
Eli Lilly CEO Says No Big Deals
WSJ Online
Wed, 06/6/12 - 05:29 pm
John Lechleiter
Pharma CEOs
Eli Lilly
M&A
Eli Lilly Launches Amyvid
Yahoo/Zacks
Mon, 06/4/12 - 05:42 pm
Eli Lilly
Amyvid
Alzheimer's disease
3 Reasons To Consider Eli Lilly
Seeking Alpha
Sun, 06/3/12 - 12:40 pm
Eli Lilly
Kowa Pharma, Eli Lilly PREVAIL US study of Livalo met primary endpoint of LDL-C reduction
Pharmabiz
Sun, 06/3/12 - 12:35 pm
Eli Lilly
Livalo
hypercholesterolemia
LDL cholesterol
CHMP in Favor of Lilly's Jentadueto
Yahoo/Zacks
Fri, 06/1/12 - 12:24 pm
Eli Lilly
Jentadueto
CHMP
diabetes
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
AstraZeneca
JNJ
Bristol-Myers Squibb
Eli Lilly
Pfizer
Sanofi
GSK
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
generics
Effient
Plavix
Brilinta
Eli Lilly
bloodthinners
AstraZeneca
Sanofi
Bristol-Myers Squibb
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters
Wed, 05/30/12 - 10:25 am
Sanofi
Novo Nordisk
Eli Lilly
diabetes
insulin
Lantus
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
ASCO
Eli Lilly
Galena Biopharma
Dendreon
Exelixis
CytRx
Array Biopharma
Ariad Pharmaceuticals
Eli Lilly announces Phase 3 study results for linagliptin
The Fly on the Wall
Thu, 05/24/12 - 10:01 am
Eli Lilly
linagliptin
diabetes
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Pharma Times, UK
Wed, 05/23/12 - 12:05 pm
Eli Lilly
dulaglutide
diabetes
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »